Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018

BACKGROUND: A novel meningococcal serogroup A conjugate vaccine (MACV [MenAfriVac]) was developed as part of efforts to prevent frequent meningitis outbreaks in the African meningitis belt. The MACV was first used widely and with great success, beginning in December 2010, during initial deployment i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Infect Dis
Main Authors: Bwaka, Ado, Bita, André, Lingani, Clément, Fernandez, Katya, Durupt, Antoine, Mwenda, Jason M, Mihigo, Richard, Djingarey, Mamoudou H, Ronveaux, Olivier, Preziosi, Marie-Pierre
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Supplement Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822965/
https://ncbi.nlm.nih.gov/pubmed/31671448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz336
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki